Culture Meets Science: British High Commission Brings Award-Winning Musical to India to Raise Awareness on Antimicrobial Resistance
‘Lifeline’ Uses Storytelling and Live Performance to Highlight the Growing Threat of Drug-Resistant Infections
By Suman Munshi, IBG NEWS Desk
New Delhi, June 29: In a unique blend of culture and science, the British High Commission hosted the India premiere of the acclaimed Scottish musical ‘Lifeline’ in New Delhi on Sunday, aiming to raise public awareness about the growing global threat of Antimicrobial Resistance (AMR). The event also marked the beginning of preparations for a multi-city India tour of the full production, scheduled for 2027.
Held at the British Council in New Delhi, the 60-minute performance featured artists from London’s West End and Broadway and brought together senior representatives from the Government of India, healthcare, academia, industry, philanthropy and scientific research institutions.
Tackling a Global Health Crisis Through Art
Antimicrobial Resistance occurs when medicines, particularly antibiotics, become ineffective against infections, making once-treatable diseases increasingly difficult to cure. Recognised as one of the world’s most pressing public health challenges, AMR threatens global healthcare systems and future pandemic preparedness.
The British High Commission believes that engaging audiences through storytelling and live theatre can make the scientific issue more accessible and inspire meaningful public action.
UK-India Partnership on AMR
Speaking at the event, Sarah Cooper, Minister Counsellor and Director for Climate, Development, Science and Technology at the British High Commission, said drug-resistant infections represent a serious and growing challenge for both India and the United Kingdom.
She noted that the two countries have collaborated for several years in strengthening laboratories, supporting scientific research, developing innovative diagnostics and building evidence-based policies to combat AMR.
“This musical demonstrates that antimicrobial resistance is not only an issue for scientists and policymakers—it is a conversation that belongs to everyone. Through creativity and performance, we can inspire new audiences to understand and act on this critical global challenge,” she said.
Vision 2035 Strengthens Healthcare Collaboration
Technology, innovation and healthcare remain central pillars of the UK-India Vision 2035 partnership. Within this framework, combating AMR has become a priority area, supporting joint efforts in pandemic preparedness, vaccine research and protecting populations against future infectious disease threats.
The collaboration extends across human health, animal health and environmental surveillance, reflecting a comprehensive One Health approach.
Significant Investments in Research and Innovation
The United Kingdom has made substantial investments to strengthen India’s capacity to combat antimicrobial resistance.
Key initiatives include:
- More than £10 million invested by UK Research and Innovation (UKRI) through multiple collaborative research programmes.
- Around £600,000 invested through the Fleming Fund to strengthen laboratory networks and AMR surveillance across India.
- A £4.8 million partnership between the UK’s Global Innovation Fund and Bengaluru-based Centre for Cellular and Molecular Platforms (C-CAMP) to develop innovative solutions for environmental AMR challenges, including technologies to remove antibiotic residues from wastewater and portable field devices to monitor antimicrobial resistance.
Award-Winning Musical with Global Impact
Created by Charades Theatre Company, Lifeline has previously been performed at the Edinburgh Festival Fringe, staged more than 40 times across the United States, and showcased at the United Nations General Assembly.
According to research published in Nature Medicine, between 74 and 80 per cent of audiences reported feeling more motivated to take action against drug-resistant infections after watching the production.
India Tour Planned for 2027
The British High Commission announced plans to bring the full production of Lifeline to multiple Indian cities in 2027, further strengthening public engagement on antimicrobial resistance through the powerful medium of performing arts.
The initiative reflects the growing commitment of both India and the United Kingdom to combine scientific collaboration with public outreach, ensuring that awareness about antimicrobial resistance reaches communities beyond laboratories and policy forums.
— IBG NEWSCulture Meets Science: British High Commission Brings Award-Winning Musical to India to Raise Awareness on Antimicrobial Resistance
‘Lifeline’ Uses Storytelling and Live Performance to Highlight the Growing Threat of Drug-Resistant Infections
New Delhi, June 29: In a unique blend of culture and science, the British High Commission hosted the India premiere of the acclaimed Scottish musical ‘Lifeline’ in New Delhi on Sunday, aiming to raise public awareness about the growing global threat of Antimicrobial Resistance (AMR). The event also marked the beginning of preparations for a multi-city India tour of the full production, scheduled for 2027.
Held at the British Council in New Delhi, the 60-minute performance featured artists from London’s West End and Broadway and brought together senior representatives from the Government of India, healthcare, academia, industry, philanthropy and scientific research institutions.
Tackling a Global Health Crisis Through Art
Antimicrobial Resistance occurs when medicines, particularly antibiotics, become ineffective against infections, making once-treatable diseases increasingly difficult to cure. Recognised as one of the world’s most pressing public health challenges, AMR threatens global healthcare systems and future pandemic preparedness.
The British High Commission believes that engaging audiences through storytelling and live theatre can make the scientific issue more accessible and inspire meaningful public action.
UK-India Partnership on AMR
Speaking at the event, Sarah Cooper, Minister Counsellor and Director for Climate, Development, Science and Technology at the British High Commission, said drug-resistant infections represent a serious and growing challenge for both India and the United Kingdom.
She noted that the two countries have collaborated for several years in strengthening laboratories, supporting scientific research, developing innovative diagnostics and building evidence-based policies to combat AMR.
“This musical demonstrates that antimicrobial resistance is not only an issue for scientists and policymakers—it is a conversation that belongs to everyone. Through creativity and performance, we can inspire new audiences to understand and act on this critical global challenge,” she said.
Vision 2035 Strengthens Healthcare Collaboration
Technology, innovation and healthcare remain central pillars of the UK-India Vision 2035 partnership. Within this framework, combating AMR has become a priority area, supporting joint efforts in pandemic preparedness, vaccine research and protecting populations against future infectious disease threats.
The collaboration extends across human health, animal health and environmental surveillance, reflecting a comprehensive One Health approach.
Significant Investments in Research and Innovation
The United Kingdom has made substantial investments to strengthen India’s capacity to combat antimicrobial resistance.
Key initiatives include:
- More than £10 million invested by UK Research and Innovation (UKRI) through multiple collaborative research programmes.
- Around £600,000 invested through the Fleming Fund to strengthen laboratory networks and AMR surveillance across India.
- A £4.8 million partnership between the UK’s Global Innovation Fund and Bengaluru-based Centre for Cellular and Molecular Platforms (C-CAMP) to develop innovative solutions for environmental AMR challenges, including technologies to remove antibiotic residues from wastewater and portable field devices to monitor antimicrobial resistance.
Award-Winning Musical with Global Impact
Created by Charades Theatre Company, Lifeline has previously been performed at the Edinburgh Festival Fringe, staged more than 40 times across the United States, and showcased at the United Nations General Assembly.
According to research published in Nature Medicine, between 74 and 80 per cent of audiences reported feeling more motivated to take action against drug-resistant infections after watching the production.
India Tour Planned for 2027
The British High Commission announced plans to bring the full production of Lifeline to multiple Indian cities in 2027, further strengthening public engagement on antimicrobial resistance through the powerful medium of performing arts.
The initiative reflects the growing commitment of both India and the United Kingdom to combine scientific collaboration with public outreach, ensuring that awareness about antimicrobial resistance reaches communities beyond laboratories and policy forums.
— IBG NEWS
